BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34983849)

  • 1. Machine learning-driven multiscale modeling reveals lipid-dependent dynamics of RAS signaling proteins.
    Ingólfsson HI; Neale C; Carpenter TS; Shrestha R; López CA; Tran TH; Oppelstrup T; Bhatia H; Stanton LG; Zhang X; Sundram S; Di Natale F; Agarwal A; Dharuman G; Kokkila Schumacher SIL; Turbyville T; Gulten G; Van QN; Goswami D; Jean-Francois F; Agamasu C; Chen D; Hettige JJ; Travers T; Sarkar S; Surh MP; Yang Y; Moody A; Liu S; Van Essen BC; Voter AF; Ramanathan A; Hengartner NW; Simanshu DK; Stephen AG; Bremer PT; Gnanakaran S; Glosli JN; Lightstone FC; McCormick F; Nissley DV; Streitz FH
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34983849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning-Driven Multiscale Modeling: Bridging the Scales with a Next-Generation Simulation Infrastructure.
    Ingólfsson HI; Bhatia H; Aydin F; Oppelstrup T; López CA; Stanton LG; Carpenter TS; Wong S; Di Natale F; Zhang X; Moon JY; Stanley CB; Chavez JR; Nguyen K; Dharuman G; Burns V; Shrestha R; Goswami D; Gulten G; Van QN; Ramanathan A; Van Essen B; Hengartner NW; Stephen AG; Turbyville T; Bremer PT; Gnanakaran S; Glosli JN; Lightstone FC; Nissley DV; Streitz FH
    J Chem Theory Comput; 2023 May; 19(9):2658-2675. PubMed ID: 37075065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-Sorting Specificity Encoded in K-Ras Membrane Anchor Regulates Signal Output.
    Zhou Y; Prakash P; Liang H; Cho KJ; Gorfe AA; Hancock JF
    Cell; 2017 Jan; 168(1-2):239-251.e16. PubMed ID: 28041850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structural model of a Ras-Raf signalosome.
    Mysore VP; Zhou ZW; Ambrogio C; Li L; Kapp JN; Lu C; Wang Q; Tucker MR; Okoro JJ; Nagy-Davidescu G; Bai X; Plückthun A; Jänne PA; Westover KD; Shan Y; Shaw DE
    Nat Struct Mol Biol; 2021 Oct; 28(10):847-857. PubMed ID: 34625747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building insights into KRAS signaling complexes.
    Hancock JF; Gorfe AA
    Nat Struct Mol Biol; 2021 Oct; 28(10):773-774. PubMed ID: 34625745
    [No Abstract]   [Full Text] [Related]  

  • 6. The Plasma Membrane as a Competitive Inhibitor and Positive Allosteric Modulator of KRas4B Signaling.
    Neale C; García AE
    Biophys J; 2020 Mar; 118(5):1129-1141. PubMed ID: 32027820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
    Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Modeling Reveals that Signaling Lipids Modulate the Orientation of K-Ras4A at the Membrane Reflecting Protein Topology.
    Li ZL; Buck M
    Structure; 2017 Apr; 25(4):679-689.e2. PubMed ID: 28286004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior.
    Goswami D; Chen D; Yang Y; Gudla PR; Columbus J; Worthy K; Rigby M; Wheeler M; Mukhopadhyay S; Powell K; Burgan W; Wall V; Esposito D; Simanshu DK; Lightstone FC; Nissley DV; McCormick F; Turbyville T
    Elife; 2020 Jan; 9():. PubMed ID: 31958057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine 170 is an Environmentally Sensitive Membrane Anchor in the Disordered HVR of K-Ras4B.
    Neale C; García AE
    J Phys Chem B; 2018 Nov; 122(44):10086-10096. PubMed ID: 30351122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Modulators of K-Ras-Membrane Interactions.
    Morstein J; Shrestha R; Van QN; López CA; Arora N; Tonelli M; Liang H; Chen D; Zhou Y; Hancock JF; Stephen AG; Turbyville TJ; Shokat KM
    ACS Chem Biol; 2023 Sep; 18(9):2082-2093. PubMed ID: 37579045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the Conformational and Energy Landscapes of KRAS Membrane Orientation.
    Prakash P; Gorfe AA
    J Phys Chem B; 2019 Oct; 123(41):8644-8652. PubMed ID: 31554397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins.
    Pincus MR
    Front Biosci; 2004 Sep; 9():3486-509. PubMed ID: 15353372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the α4-α5 interface of RAS results in multiple levels of inhibition.
    Spencer-Smith R; Li L; Prasad S; Koide A; Koide S; O'Bryan JP
    Small GTPases; 2019 Sep; 10(5):378-387. PubMed ID: 28692342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the Dynamics of KRAS4b on Lipid Model Membranes.
    López CA; Agarwal A; Van QN; Stephen AG; Gnanakaran S
    J Membr Biol; 2021 Apr; 254(2):201-216. PubMed ID: 33825026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function.
    Cao S; Chung S; Kim S; Li Z; Manor D; Buck M
    J Biol Chem; 2019 Apr; 294(17):7068-7084. PubMed ID: 30792310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
    Nussinov R; Tsai CJ; Jang H
    Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput, single-particle tracking reveals nested membrane domains that dictate KRas
    Lee Y; Phelps C; Huang T; Mostofian B; Wu L; Zhang Y; Tao K; Chang YH; Stork PJ; Gray JW; Zuckerman DM; Nan X
    Elife; 2019 Nov; 8():. PubMed ID: 31674905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane transporter dimerization driven by differential lipid solvation energetics of dissociated and associated states.
    Chadda R; Bernhardt N; Kelley EG; Teixeira SC; Griffith K; Gil-Ley A; Öztürk TN; Hughes LE; Forsythe A; Krishnamani V; Faraldo-Gómez JD; Robertson JL
    Elife; 2021 Apr; 10():. PubMed ID: 33825681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.